Army Hospital General L. Svoboda Svidnik a.s.
- Address
- lock Available on a paid plan
Respiratory Tract Diseases
At Army Hospital General L. Svoboda Svidnik a.s., research in respiratory tract diseases focuses on community-acquired pneumonia and COVID-19 pneumonia, with studies designed to assess whether new supportive treatments can improve recovery in hospitalized adults.
- Non-severe community-acquired pneumonia and moderate to severe COVID-19
- Testing an added treatment approach to improve outcomes alongside standard care
These trials reflect a broader effort to strengthen care for serious lung infections and related complications in hospitalized patients.
Bacterial Infections and Mycoses
Clinical research in bacterial infections at this site includes studies of difficult-to-treat infections such as complicated urinary tract infection, acute pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, and complicated intra-abdominal infection, with the goal of evaluating new antibiotic options.
- Complicated urinary tract infection and acute uncomplicated pyelonephritis
- Hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, and complicated intra-abdominal infection
- Assessing safety and effectiveness of treatments against resistant bacteria
The work is especially focused on infections caused by carbapenem-resistant Enterobacterales, an important area for improving treatment choices in hospitalized patients.
Nutritional and Metabolic Diseases
Studies in nutritional and metabolic diseases are centered on severe hypertriglyceridemia, exploring whether a new therapy can safely lower very high triglyceride levels and improve lipid control.
- Severe hypertriglyceridemia
- Evaluating a therapy aimed at reducing fasting triglycerides
- Measuring safety and tolerability alongside treatment effect
This area highlights the site’s interest in metabolic conditions that can raise the risk of serious cardiovascular and pancreatic complications.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The site’s portfolio also includes this broader therapeutic area, showing involvement in research that may address inherited or early-life health conditions, even when the main focus of current trials is on infections and metabolic disorders.
- Congenital and hereditary disease research
- Potential support for studies that improve diagnosis or treatment in complex patient groups
At the Interné oddelenie, this adds to a diverse clinical research profile supported by a small investigator team.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Micurx Pharmaceuticals Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ionis Pharmaceuticals Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Army Hospital General L. Svoboda Svidnik a.s.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections | Micurx Pharmaceuticals Inc. | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aztreonam | 3 | Unknown | 2023-03-17 | 2023-06-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.